The antigenic anatomy of SARS-CoV-2 receptor binding domain
Journal article
GUPTA S. et al, (2021), Cell
Promises and challenges of adoptive T-cell therapies for solid tumours
Journal article
AHMED A. et al, (2021), British Journal of Cancer
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Journal article
Barrett JR. et al, (2020), Nat Med
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Journal article
Ewer KJ. et al, (2020), Nat Med
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Journal article
Voysey M. et al, (2020), Lancet
Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases.
Journal article
Yao X. et al, (2020), Breathe (Sheff), 16
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison.
Journal article
National SARS-CoV-2 Serology Assay Evaluation Group None., (2020), Lancet Infect Dis, 20, 1390 - 1400
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Journal article
Ramasamy MN. et al, (2020), Lancet
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.
Journal article
Peng Y. et al, (2020), Nat Immunol, 21, 1336 - 1345
IFITM3-specific antibody reveals interferon preferences and slow interferon induction of the anti-viral factor IFITM3 in humans
Journal article
WELLINGTON D. et al, (2020), European Journal of Immunology
Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments.
Journal article
Kanellakis NI. et al, (2020), Thorax
Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro
Conference paper
Asciak R. et al, (2020), EUROPEAN RESPIRATORY JOURNAL, 56
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
Journal article
Folegatti PM. et al, (2020), Lancet, 396, 467 - 478
Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease.
Journal article
Zhao Y. et al, (2020), JCI Insight, 5
Human cancer germline antigen-specific cytotoxic T cell-what can we learn from patient.
Journal article
Abd Hamid M. et al, (2020), Cell Mol Immunol, 17, 684 - 692
Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients.
Journal article
Peng Y. et al, (2020), bioRxiv
A novel scoring system for prediction of disease severity in COVID-19
Journal article
DONG TAO., (2020), Frontiers in Cellular and Infection Microbiology, section Virus and Host
Longitudinal profiling of cytokines and chemokines in COVID-19 reveals inhibitory mediators IL-1Ra and IL-10 are associated with disease severity while elevated RANTES is an early predictor of mild disease
Journal article
DONG TAO. et al, (2020), Preprint with Lancet
Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with disease severity in COVID-19
Journal article
Zhang Y. et al, (2020), The Journal of Infectious Diseases
Clinical and epidemiological features of COVID-19 family clusters in Beijing, China.
Journal article
Song R. et al, (2020), J Infect